NMN supplement trial for middle-aged adults with metabolic issues
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 70 years old and your body mass index (BMI) is 24 or higher (overweight or obese).
- You have at least one of the following: fatty liver disease (seen on ultrasound), pre-diabetes, or type 2 diabetes with A1c under 7% and not on diabetes medication.
- You can come to the hospital for scheduled visits and agree to take part in the study.
- You have not used NMN or any anti-aging supplements in the last 6 months.
- You are not currently taking glucose-lowering drugs for diabetes.
- You do not have tumors, autoimmune diseases (except Hashimoto's thyroiditis), severe heart or lung disease, uncontrolled high blood pressure (above 160/100 mmHg), liver or kidney failure, stroke history, blood disorders, active infections, or mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if nicotinamide mononucleotide (NMN), a natural supplement, can help middle-aged and older adults stay healthy. It aims to see if NMN can slow aging-related changes in healthy people between 40-70 years old.
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.
This trial tests whether taking an NMN supplement can help improve the immune system (CD4+ T cells) in people with HIV who have not seen enough immune recovery despite effective antiretroviral therapy.
This study looks at how the body uses NAD+ precursors (nutrients that help cells produce energy) after taking them by mouth. Healthy volunteers will help researchers understand how these supplements are processed, which may guide future treatments for aging and disease.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.
This trial tests how well a new injectable form of Niagen (a supplement that may boost cellular energy) is absorbed and tolerated compared to NAD+. It may help if you are between 40 and 65, live near the study site, and feel unusually tired.
Hear when a new Immunosenescence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.